Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance

详细信息    查看全文

• 作者：E. Michael Lewiecki ; ¹ ; ^{mlewiecki@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Neil Binkley² ; Sarah L. Morgan³ ; Christopher R. Shuhart⁴ ; Bruno Muzzi Camargos⁵ ; John J. Carey⁶ ; Catherine M. Gordon⁷ ; Lawrence G. Jankowski⁸ ; Joon-Kiong Lee⁹ ; William D. Leslie¹⁰ ; on behalf of the International Society for Clinical Densitometry
• 关键词：Accreditation ; certification ; DXA ; osteoporosis ; quality
• 刊名：Journal of Clinical Densitometry
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：19
• 期：2
• 页码：127-140
• 全文大小：218 K

文摘

Dual-energy X-ray absorptiometry (DXA) is a technology that is widely used to diagnose osteoporosis, assess fracture risk, and monitor changes in bone mineral density (BMD). The clinical utility of DXA is highly dependent on the quality of the scan acquisition, analysis, and interpretation. Clinicians are best equipped to manage patients when BMD measurements are correct and interpretation follows well-established standards. Poor-quality acquisition, analysis, or interpretation of DXA data may mislead referring clinicians, resulting in unnecessary diagnostic evaluations, failure to evaluate when needed, inappropriate treatment, or failure to provide medical treatment, with potentially ineffective, harmful, or costly consequences. Misallocation of limited healthcare resources and poor treatment decisions can be minimized, and patient care optimized, through meticulous attention to DXA instrument calibration, data acquisition and analysis, interpretation, and reporting. This document from the International Society for Clinical Densitometry describes quality standards for BMD testing at DXA facilities worldwide to provide guidance for DXA supervisors, technologists, interpreters, and clinicians. High-quality DXA testing is necessary for correct diagnostic classification and optimal fracture risk assessment, and is essential for BMD monitoring.